IUPAC name
4-chloro-N-[2-(morpholin-4-yl)ethyl]benzamide
SMILES
ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1
Compound class
Antidepressive Agents; Monoamine Oxidase Inhibitors; Nervous System; Antidepressants; Psychoanaleptics; Monoamine Oxidase a Inhibitors; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9 Inhibitors; Cytochrome P-450 CYP1A2 Inducers; Cytochrome P-450 CYP2C9 Inducers; Cytochrome P-450 CYP2C19 Inducers; CYP2D6 Inducers; CYP2D6 Inducers (strong);
Therapeutic area
For the treatment of depression.
Common name
Moclobemide
IUPAC name
4-chloro-N-[2-(morpholin-4-yl)ethyl]benzamide
SMILES
ClC1=CC=C(C=C1)C(=O)NCCN1CCOCC1
INCHI
InChI=1S/C13H17ClN2O2/c14-12-3-1-11(2-4-12)13(17)15-5-6-16-7-9-18-10-8-16/h1-4H,5-10H2,(H,15,17)
FORMULA
C13H17ClN2O2
Common name
Moclobemide
IUPAC name
4-chloro-N-[2-(morpholin-4-yl)ethyl]benzamide
Molecular weight
268.739
clogP
2.336
clogS
-3.405
HBond Acceptor
3
HBond Donor
1
Total Polar Surface Area
41.57
Number of Rings
2
Rotatable Bond
4
| Drug ID | Common name | Structure CAS | SMILE | Frequency |
|---|---|---|---|---|
| FDBF00003 | formamide |
|
C(=O)N | 0.1240 |
| FDBF00016 | chlorobenzene |
|
c1ccc(cc1)Cl | 0.0718 |
| FDBF00484 | morpholine |
|
O1CCNCC1 | 0.0082 |
| FDBF00710 | 4-methylmorpholine |
|
O1CCN(CC1)C | 0.0052 |
| FDBF00714 | 4-ethylmorpholine |
|
O1CCN(CC1)CC | 0.0031 |
| FDBF01839 | 4-chlorobenzamide |
|
O=C(N)c1ccc(cc1)Cl | 0.0017 |
| FDBF02659 | 4-chloro-N-methyl-benzamide |
|
Clc1ccc(cc1)C(=O)NC | 0.0007 |
| FDBF02660 | N-(2-morpholinoethyl)formamide |
|
O1CCN(CC1)CCNC=O | 0.0003 |
| FDBF02661 | 4-chloro-N-ethyl-benzamide |
|
Clc1ccc(cc1)C(=O)NCC | 0.0007 |
9 ,
1
